ENANTA PHARMACEUTICALS (ENTA) Covered Calls

ENANTA PHARMACEUTICALS covered calls Enanta Pharmaceuticals Inc is a research and development focused biotechnology company. It uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field.

You can sell covered calls on ENANTA PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ENTA (prices last updated Tue 4:16 PM ET):

ENANTA PHARMACEUTICALS (ENTA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
77.14 -0.67 74.00 90.00 263K 18 1.5B
Covered Calls For ENANTA PHARMACEUTICALS (ENTA)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 75 4.20 85.80 -12.6% -184.0%
Dec 21 75 6.50 83.50 -10.2% -62.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company, which uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. It is discovering, and in some cases developing, novel inhibitors designed for use against the hepatitis C virus. These inhibitors include members of the direct acting antiviral inhibitor classes - protease, NS5A and nucleotide polymerase - as well as a host-targeted antiviral inhibitor class targeted against cyclophilin. Additionally, the company has created a new class of antibiotics, called Bicyclolides, for the treatment of multi-drug resistant bacteria, with a focus on developing an intravenous and oral treatment for hospital and community methicillin-resistant Staphylococcus aureus infections. Enanta Pharmaceuticals was founded by Peter O. Kliem and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.